Compare
Ensign Group, Inc vs PACS Group, Inc. vs National Healthcare Corp
| Latest fiscal year | Ensign Group, Inc ENSG | PACS Group, Inc. PACS | National Healthcare Corp NHC |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $5.03B | $5.29B | $1.52B |
| Revenue growth (YoY) | +18.8% | +29.3% | +16.1% |
| Gross margin | 20.1% (computed) | n/a | n/a |
| Operating margin | 8.5% | 5.9% | 8.5% |
| Net margin | 6.8% | 3.6% | 7.9% |
| Net income | $343.97M | $191.54M | $120.02M |
| EPS (Diluted) | $5.84 | $1.22 | $7.67 |
| Operating cash flow | $564.27M | $404.22M | $185.08M |
| Free cash flow | n/a | n/a | $148.63M |
| Cash & equivalents | $503.88M | $197.02M | $92.83M |
| Total assets | $5.46B | $5.58B | $1.53B |
| Total liabilities | $3.23B | $4.63B | $451.90M |
| Shareholders' equity | $2.23B | $952.45M | $1.07B |
| Return on year-end equity | 15.4% | 20.1% | 11.2% |
| Shares outstanding | 58.09M | 156.62M | 15.54M |
Revenue, most recent five fiscal years
| Fiscal year | Ensign Group, Inc | PACS Group, Inc. | National Healthcare Corp |
|---|---|---|---|
| Latest | $5.03B Ended 2025-12-31 | $5.29B Ended 2025-12-31 | $1.52B Ended 2025-12-31 |
| 1 year earlier | $4.24B Ended 2024-12-31 | $4.09B Ended 2024-12-31 | $1.31B Ended 2024-12-31 |
| 2 years earlier | $3.71B Ended 2023-12-31 | $3.11B Ended 2023-12-31 | $1.14B Ended 2023-12-31 |
| 3 years earlier | $3.03B Ended 2022-12-31 | $2.42B Ended 2022-12-31 | $1.09B Ended 2022-12-31 |
| 4 years earlier | $2.63B Ended 2021-12-31 | n/a | $1.07B Ended 2021-12-31 |